Women Are Alarmed That Zantac May Cause Breast Cancer

Zantac breast cancer plaintiffs cite a notable scientific study that made clear the risks ranitidine carried for developing breast cancer

Tuesday, August 11, 2020 - Thousands of individuals have consulted with Zantac Cancer Lawyers and filed a claim for monetary compensation due to allegedly developing a wide range of cancer from taking Zantac heartburn and acid reflux medicine regularly and for years. The majority of lawsuits allege that Zantac causes cancer of the digestive system including the stomach, bladder, intestines, bowels, prostate, and other vital organs. Thousands of individuals have filed lawsuits and tens of thousands are expected to file suit as the news about Zantac spreads. Lawsuits against Sanofi now include breast cancer.

A 44-year-old Boynton Beach Florida woman has filed suit. According to the Palm Beach Post, Jill Goldstein, a former school psychologist, used Zantac regularly for nearly two decades before developing breast cancer. The lawsuit filed sites a 2008 study a reputable cancer institute that provided the company with all the information they needed to put public safety before profits and inform the public, which they failed to do. According to the Palm Beach Post, "According to a 2008 study by a prestigious California-based cancer research institute, those who regularly take Zantac face a 240 percent greater risk of developing ductal carcinoma than those who don't take the medication, Goldstein's attorneys said in a lawsuit filed late last month. If only the makers of Zantac had put aside their greed and heeded the 2008 peer-reviewed study by the Fred Hutchinson Cancer Research Center, Jill Goldstein would not be going through the hell she is subjected to now," attorney Yechezkel Rodal said in the 41-page lawsuit filed in U.S. District Court in West Palm Beach." Lawyers and Settlements.com cited the peer-reviewed Hutchinson Breast Cancer study earlier this year as women were coming forward accusing Zantac of being the cause of their breast cancer. Lawyers and settlements wrote, "(The Study) authored by the American Association for Cancer Research and American Society of Preventive Oncology back in 2008 concluded that the current use of ranitidine may increase the risk of hormone-receptor-positive ductal carcinoma, which is a type of breast cancer. "

There are few medical diagnoses that women fear more than being told they have breast cancer. Later finding out that it was avoidable can be heartbreaking. Sanofi, the maker of Zantac, the most popular heartburn and acid reflux medication in the world, is being accused by the Federal government of lying to government health watchdog agencies about what they knew of the potential to develop carcinogenic levels of NDMA. "The U.S. Department of Justice has opened an investigation into whether drugmakers including Sanofi SA failed to disclose to the federal government information about the potential presence of a probable carcinogen in the heartburn drug Zantac," according to Reuters. Had Sanofi been forthcoming as is the law about Zantac causing cancer, millions of lives may have been saved that have now been lost to the deadly disease.

If you or a loved one have been taking Zantac and have been diagnosed with breast cancer you may be able to file a complaint and claim monetary compensation for medical expenses, lost wages, and other damages.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.